US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vivani Medical, Inc.

1.15

+0.01000.88%

Post-market: 1.15-0.0001-0.01%19:52 EDT

Volume:64.58K

Turnover:74.11K

Market Cap:68.13M

PE:-2.75

High:1.16

Open:1.13

Low:1.13

Close:1.14

Loading ...

Overview Company News Filings

Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity

EXCLUSIVE: Vivani Medical Collaborates With Okava To Expand Development Of GLP-1 Therapy For Dogs

Insider Purchases Worth US$5.02m See Losses As Vivani Medical Market Value Drops To US$60m

Simply Wall St.

Vivani Medical Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

Vivani Medical Inc : Maxim Group Cuts Target Price to $4 From $8

THOMSON REUTERS

Vivani Medical: Q4 Earnings Snapshot

Associated Press Finance

Vivani Medical Q4 2024 GAAP EPS $(0.11), Inline, As Of December 31, 2024, Vivani Had Cash, Cash Equivalents And Restricted Cash Totaling $19.7M, Additional $8.25M Equity Financing Which Secures Solid Financial Position Into Q2 Of 2026

Vivani Medical FY Basic EPS USD -0.43

THOMSON REUTERS

Press Release: Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

BRIEF-Vivani Medical Announces $8.25M Private Placement Equity Financing

Vivani Medical Announces $8.25M Private Placement Equity Financing

THOMSON REUTERS

Vivani Medical Inc - Proceeds to Extend Cash Runway Into Q2 2026

THOMSON REUTERS

Press Release: Vivani Medical Announces $8.25M Private Placement Equity Financing

Vivani Medical Gives Data for Weight Loss Implant

Vivani Medical Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

Vivani Medical Announces Positive Preclinical Weight Loss Data for Npm-139 Semaglutide Implant, With Potential for Once-Yearly Dosing

THOMSON REUTERS

Vivani Medical Inc - Nanoportal Technology Successfully Delivers Semaglutide in Preclinical Study

THOMSON REUTERS

Vivani Medical Inc - Npm-139 Treatment Results in Nearly 20% Placebo-Adjusted Weight Loss

THOMSON REUTERS

Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing

EXCLUSIVE: Vivani Medical Subdermal Semaglutide Implant Shows 20% Weight Loss In Animal Study, With Potential For Once-Yearly Dosing

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/VANI/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VANI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VANI\",,,,,undefined,":{"symbol":"VANI","market":"US","secType":"STK","nameCN":"Vivani Medical, Inc.","latestPrice":1.15,"timestamp":1750190400000,"preClose":1.14,"halted":0,"volume":64581,"hourTrading":{"tag":"盘后","latestPrice":1.1499,"preClose":1.15,"latestTime":"19:52 EDT","volume":1878,"amount":2139.1581,"timestamp":1750204335088},"delay":0,"floatShares":30972594,"shares":59243903,"eps":-0.418562,"marketStatus":"Closed","change":0.01,"latestTime":"06-17 16:00:00 EDT","open":1.13,"high":1.16,"low":1.13,"amount":74105.4381705,"amplitude":0.026316,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.418562,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750233600000},"marketStatusCode":5,"adr":0,"listingDate":1416373200000,"exchange":"NASDAQ","adjPreClose":1.14,"preHourTrading":{"tag":"盘前","latestPrice":1.19,"preClose":1.14,"latestTime":"08:33 EDT","volume":45,"amount":53.670006,"timestamp":1750163601451},"postHourTrading":{"tag":"盘后","latestPrice":1.1499,"preClose":1.15,"latestTime":"19:52 EDT","volume":1878,"amount":2139.1581,"timestamp":1750204335088},"volumeRatio":0.604904,"impliedVol":2.7819,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VANI\",,,,,undefined,":{"symbol":"VANI","floatShares":30972594,"roa":"-35.03%","roe":"-117.76%","lyrEps":-0.427165,"volumeRatio":0.604904,"shares":59243903,"dividePrice":0,"high":1.16,"amplitude":0.026316,"preClose":1.14,"low":1.13,"week52Low":0.9054,"pbRate":"5.86","week52High":1.6,"institutionHeld":0,"latestPrice":1.15,"eps":-0.418562,"divideRate":0,"volume":64581,"delay":0,"ttmEps":-0.418562,"open":1.13,"prevYearClose":1.16,"prevWeekClose":1.15,"prevMonthClose":1.26,"prevQuarterClose":1.05,"fiveDayClose":1.17,"twentyDayClose":1.07,"sixtyDayClose":1.09},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VANI\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527241597","title":"Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity","url":"https://stock-news.laohu8.com/highlight/detail?id=2527241597","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527241597?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:30","pubTimestamp":1744720200,"startTime":"0","endTime":"0","summary":"Over half of all dogs in the United States today are overweight or obese, placing them at increased risk for chronic diseases, metabolic decline and shortened lifespansALAMEDA, Calif. and SAN FRANCISC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/15/3061726/0/en/Vivani-Medical-and-Okava-Expand-Collaboration-to-Develop-OKV-119-for-Dogs-Targeting-Metabolic-Health-and-Longevity.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2527241371","title":"EXCLUSIVE: Vivani Medical Collaborates With Okava To Expand Development Of GLP-1 Therapy For Dogs","url":"https://stock-news.laohu8.com/highlight/detail?id=2527241371","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527241371?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:03","pubTimestamp":1744718612,"startTime":"0","endTime":"0","summary":"Vivani Medical, Inc.  and Okava Pharmaceuticals, Inc. expanded their collaboration to include dogs in the development of OKV-119, a long-acting GLP-1 therapy for weight management, diabetes and other cardiometabolic conditions.Financial terms of the expanded agreement were not disclosed.Okava Pharmaceuticals is a clinical-stage company focused on diseases of aging in dogs and cats.Vivani and Okava initiated their collaboration in 2019, focusing on developing OKV-119 for cardiometabolic conditions in cats.Also Read: EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder Value. OKV-119 leverages Vivani's proprietary NanoPortal technology, which provides smooth and steady delivery of therapeutic molecules, including GLP-1 receptor agonists, over extended periods from a single implant.According to Okava, dosing every six months or longer supports a \"One-and-Done\" approach between office visits consistent with ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-vivani-medical-collaborates-okava-120332479.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4590","VANI","GLP","BK4082","BK4144"],"gpt_icon":0},{"id":"2524842237","title":"Insider Purchases Worth US$5.02m See Losses As Vivani Medical Market Value Drops To US$60m","url":"https://stock-news.laohu8.com/highlight/detail?id=2524842237","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524842237?lang=en_us&edition=fundamental","pubTime":"2025-04-04 22:07","pubTimestamp":1743775622,"startTime":"0","endTime":"0","summary":"Insiders who bought US$5.02m worth of Vivani Medical, Inc.'s ( NASDAQ:VANI ) stock at an average buy price of US$1.26...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-vani/vivani-medical/news/insider-purchases-worth-us502m-see-losses-as-vivani-medical","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2524208236","title":"Vivani Medical Price Target Maintained With a $4.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2524208236","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524208236?lang=en_us&edition=fundamental","pubTime":"2025-04-04 19:16","pubTimestamp":1743765360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VANI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 04, 2025 07:16 ET (11:16 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI"],"gpt_icon":0},{"id":"2524583139","title":"Vivani Medical Inc : Maxim Group Cuts Target Price to $4 From $8","url":"https://stock-news.laohu8.com/highlight/detail?id=2524583139","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524583139?lang=en_us&edition=fundamental","pubTime":"2025-04-01 12:10","pubTimestamp":1743480611,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QE1AS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","VANI"],"gpt_icon":0},{"id":"2523945961","title":"Vivani Medical: Q4 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2523945961","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523945961?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:50","pubTimestamp":1743421819,"startTime":"0","endTime":"0","summary":"ALAMEDA, Calif.  — ALAMEDA, Calif.  — Vivani Medical, Inc.  on Monday reported a loss of $6.1 million in its fourth quarter.On a per-share basis, the Alameda, California-based company said it had a loss of 11 cents.For the year, the company reported a loss of $23.5 million, or 43 cents per share.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vivani-medical-q4-earnings-snapshot-115019237.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VANI"],"gpt_icon":0},{"id":"2523948138","title":"Vivani Medical Q4 2024 GAAP EPS $(0.11), Inline, As Of December 31, 2024, Vivani Had Cash, Cash Equivalents And Restricted Cash Totaling $19.7M, Additional $8.25M Equity Financing Which Secures Solid Financial Position Into Q2 Of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2523948138","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523948138?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:36","pubTimestamp":1743420983,"startTime":"0","endTime":"0","summary":"Vivani Medical (NASDAQ:VANI) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a 8.33 percent increase over losses of $(0.12) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44558815/vivani-medical-q4-2024-gaap-eps-0-11-inline-as-of-december-31-2024-vivani-had-cash-cash-equivalents","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EQR","VANI"],"gpt_icon":0},{"id":"2523691007","title":"Vivani Medical FY Basic EPS USD -0.43","url":"https://stock-news.laohu8.com/highlight/detail?id=2523691007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523691007?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:30","pubTimestamp":1743420600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nPLX492929:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","VANI"],"gpt_icon":0},{"id":"2523394835","title":"Press Release: Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2523394835","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523394835?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:30","pubTimestamp":1743420600,"startTime":"0","endTime":"0","summary":"Successful initial administration and full enrollment in first-in-human LIBERATE-1 study of NPM-115.  in obese and overweight subjects with top-line data expected in mid-2025. Positive NPM-139  preclinical weight loss data comparable to. \"During 2024, we transitioned Vivani to a clinical-stage biotechnology company and achieved significant milestones in both our NPM-115 and NPM-139 programs, both focused on transforming the treatment of chronic weight management targeting once or twice-yearly dosing,\" said Adam Mendelsohn, Ph.D., Vivani's Chief Executive Officer, \"Our first-in-human LIBERATE-1 study continues to progress as planned with each implantation to date having been successful and we remain on track for top-line data in mid-2025. By providing key performance data on drug release, the value of LIBERATE-1 extends beyond the NPM-115 program by also informing the NPM-139 program as it advances in parallel.\". On March 27, 2025, Vivani announced an $8.25 million equity financing whic","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","BK4082","BK4099","BK4588","BK4555","BK6502","BK6097","BK4232","R","BK4022","VANI","BK4585","BK4604","CRGT","03160","5OX.SI"],"gpt_icon":0},{"id":"2522379023","title":"BRIEF-Vivani Medical Announces $8.25M Private Placement Equity Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2522379023","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522379023?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:33","pubTimestamp":1743075203,"startTime":"0","endTime":"0","summary":"BRIEF-Vivani Medical Announces $8.25M Private Placement Equity FinancingMarch 27 (Reuters) - Vivani Medical Inc VANI.O:VIVANI MEDICAL ANNOUNCES $8.25M PRIVATE PLACEMENT EQUITY FINANCINGVIVANI MEDICAL ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA5VC6Q8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2522792083","title":"Vivani Medical Announces $8.25M Private Placement Equity Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2522792083","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522792083?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:32","pubTimestamp":1743075176,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA5VC6Q8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2522379748","title":"Vivani Medical Inc - Proceeds to Extend Cash Runway Into Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2522379748","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522379748?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:32","pubTimestamp":1743075176,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA5VC6Q8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","VANI"],"gpt_icon":0},{"id":"2522637191","title":"Press Release: Vivani Medical Announces $8.25M Private Placement Equity Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2522637191","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522637191?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:32","pubTimestamp":1743075120,"startTime":"0","endTime":"0","summary":"Financing strengthens balance sheet, extending expected runway into the second quarter of 2026. Enables accelerated development of NPM-139, Company's once or twice-yearly GLP-1  implant under development for chronic weight management. The Company expects the gross proceeds from this private placement to extend its cash runway into the second quarter of 2026, enabling accelerated development of NPM-139, its once or twice-yearly GLP-1  implant under development for chronic weight management, and continued development of NPM-115, its twice-yearly GLP-1  implant which is also under development for chronic weight management.Leveraging its proprietary NanoPortal platform, Vivani develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve patient tolerance to their medication. Vivani's lead program, NPM-115, is a six-month, subdermal, GLP-1  implant under development for chron","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","03160","BK4585","TM","BK4604","EQR","BK4588","BK4555","BK4099","BK4215","VANI"],"gpt_icon":0},{"id":"2522332796","title":"Vivani Medical Gives Data for Weight Loss Implant","url":"https://stock-news.laohu8.com/highlight/detail?id=2522332796","media":"Exec Edge","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522332796?lang=en_us&edition=fundamental","pubTime":"2025-03-27 02:51","pubTimestamp":1743015067,"startTime":"0","endTime":"0","summary":"Vivani Medical, Inc.  announced positive data for NPM-139, its subdermal semaglutide implant for chronic weight management, with expected once or twice-yearly dosing.The results support the company’s NanoPortal implant for delivery of therapeutic molecules for obesity and type 2 diabetes, Vivani stated.“This preclinical demonstration of NPM-139 comes on the heels of having rapidly enrolled and successfully implanted an initial group of subjects in LIBERATE-1, our first-in-human study with NPM-115, which we expect will pave the road for NPM-139 as development continues for both programs,” said Adam Mendelsohn, Ph.D., Vivani Medical’s CEO.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vivani-medical-gives-data-weight-185107102.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2522847453","title":"Vivani Medical Price Target Maintained With a $4.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2522847453","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522847453?lang=en_us&edition=fundamental","pubTime":"2025-03-26 23:57","pubTimestamp":1743004620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VANI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 26, 2025 11:57 ET (15:57 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI"],"gpt_icon":0},{"id":"2522875401","title":"Vivani Medical Announces Positive Preclinical Weight Loss Data for Npm-139 Semaglutide Implant, With Potential for Once-Yearly Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2522875401","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522875401?lang=en_us&edition=fundamental","pubTime":"2025-03-26 19:30","pubTimestamp":1742988627,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nFWN3Q90LF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2522287540","title":"Vivani Medical Inc - Nanoportal Technology Successfully Delivers Semaglutide in Preclinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2522287540","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522287540?lang=en_us&edition=fundamental","pubTime":"2025-03-26 19:30","pubTimestamp":1742988627,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nFWN3Q90LF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VANI","BK4082"],"gpt_icon":0},{"id":"2522087542","title":"Vivani Medical Inc - Npm-139 Treatment Results in Nearly 20% Placebo-Adjusted Weight Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2522087542","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522087542?lang=en_us&edition=fundamental","pubTime":"2025-03-26 19:30","pubTimestamp":1742988627,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nFWN3Q90LF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","VANI"],"gpt_icon":0},{"id":"2522287658","title":"Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2522287658","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522287658?lang=en_us&edition=fundamental","pubTime":"2025-03-26 19:30","pubTimestamp":1742988600,"startTime":"0","endTime":"0","summary":"NanoPortaltechnology successfully delivers semaglutide, the active ingredient in Ozempic/Wegovy, in a preclinical study with NPM-139 (semaglutide implant) NPM-139 treatment resulted in nearly 20% plac","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/26/3049520/0/en/Vivani-Medical-Announces-Positive-Preclinical-Weight-Loss-Data-for-NPM-139-Semaglutide-Implant-with-Potential-for-Once-Yearly-Dosing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VANI"],"gpt_icon":0},{"id":"2522878824","title":"EXCLUSIVE: Vivani Medical Subdermal Semaglutide Implant Shows 20% Weight Loss In Animal Study, With Potential For Once-Yearly Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2522878824","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522878824?lang=en_us&edition=fundamental","pubTime":"2025-03-26 19:00","pubTimestamp":1742986822,"startTime":"0","endTime":"0","summary":"Vivani Medical, Inc. , on Wednesday, released preclinical data for NPM-139, its subdermal semaglutide implant under development for chronic weight management in obese and overweight individuals.Semaglutide is the active ingredient in Novo Nordisk A/S’  Ozempic and Wegovy, which are available for diabetes and weight loss.In an ongoing study in healthy rats, a single administration of the semaglutide implant NPM-139 resulted in body weights nearly 20% lower than a sham implant control group throughout a 91-day treatment period.NPM-139 treatment resulted in nearly 20% placebo-adjusted weight loss from a single administration with expected once or twice-yearly dosing.Like NPM-119 and NPM-115, NPM-139 has demonstrated smooth, non-fluctuating in vivo release. The study demonstrated continuous and steady semaglutide exposure throughout the study period.In-vitro chemical and physical stability measurements for durations exceeding one year indicate the potential for once-yearly administration o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-vivani-medical-subdermal-semaglutide-110022485.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BKVL7J92.USD","LU1093756325.SGD","VANI","BK4599","LU0154236417.USD","BK4082","BK4585","BK4007","BK4532","LU1093756168.USD","IE00BZ1G4Q59.USD","BK4588"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":54,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VANI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"VANI","fiscalQuarterEnding":"2025/03","expectedEps":-0.1,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2025-03-31","symbol":"VANI","fiscalQuarterEnding":"2024/12","expectedEps":-0.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2024-11-13","symbol":"VANI","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2024-08-13","symbol":"VANI","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-0.1},{"market":"US","date":"2024-05-13","symbol":"VANI","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":-0.12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VANI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VANI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1732161600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VANI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VANI","date":"2025-06-16","current":-2.868773,"percent":0.636364,"low":-15.317797,"twenty":-4.961933,"median":-3.137717,"eighty":-2.62184,"high":-1.630678,"avg":-3.85991,"sd":1.837327,"marketCap":68130488},"quantilePoints":[{"date":"2022-09-02","current":-11.795262,"twenty":-15.051401,"median":-14.651806,"eighty":-12.93788,"marketCap":178556678},{"date":"2022-09-09","current":-9.449613,"twenty":-14.080497,"median":-10.454891,"eighty":-9.483122,"marketCap":143048247},{"date":"2022-09-16","current":-10.857003,"twenty":-11.60761,"median":-10.036026,"eighty":-9.422806,"marketCap":164353305},{"date":"2022-09-23","current":-8.142752,"twenty":-10.843599,"median":-9.58365,"eighty":-9.114521,"marketCap":123264979},{"date":"2022-09-30","current":-7.640113,"twenty":-10.722965,"median":-9.432859,"eighty":-8.410826,"marketCap":115656030},{"date":"2022-10-07","current":-7.439057,"twenty":-10.334258,"median":-9.047502,"eighty":-8.169559,"marketCap":112612450},{"date":"2022-10-14","current":-6.567816,"twenty":-9.804812,"median":-8.578373,"eighty":-7.559691,"marketCap":99423604},{"date":"2022-10-21","current":-6.534307,"twenty":-9.610458,"median":-8.377317,"eighty":-6.842593,"marketCap":98916341},{"date":"2022-10-28","current":-6.266233,"twenty":-9.570246,"median":-8.209771,"eighty":-6.608027,"marketCap":94858235},{"date":"2022-11-04","current":-6.165705,"twenty":-9.503228,"median":-7.77415,"eighty":-6.272935,"marketCap":93336445},{"date":"2022-11-11","current":-5.663066,"twenty":-9.442911,"median":-7.489321,"eighty":-6.205916,"marketCap":85727496},{"date":"2022-11-18","current":-6.897088,"twenty":-9.409402,"median":-7.539585,"eighty":-6.239426,"marketCap":70522720},{"date":"2022-11-25","current":-7.145184,"twenty":-9.382595,"median":-7.439057,"eighty":-6.266233,"marketCap":73059508},{"date":"2022-12-02","current":-6.847468,"twenty":-9.047502,"median":-7.095565,"eighty":-6.266233,"marketCap":70015362},{"date":"2022-12-09","current":-7.988713,"twenty":-9.047502,"median":-7.439057,"eighty":-6.266233,"marketCap":81684589},{"date":"2022-12-16","current":-5.110791,"twenty":-8.812937,"median":-7.39136,"eighty":-6.266233,"marketCap":52257843},{"date":"2022-12-23","current":-4.614598,"twenty":-8.633764,"median":-7.145184,"eighty":-6.199214,"marketCap":47184266},{"date":"2022-12-30","current":-4.216155,"twenty":-8.616258,"median":-6.996326,"eighty":-6.065177,"marketCap":43110183},{"date":"2023-01-06","current":-4.733684,"twenty":-8.571671,"median":-6.946707,"eighty":-5.830613,"marketCap":48401924},{"date":"2023-01-13","current":-5.855081,"twenty":-8.538661,"median":-6.883244,"eighty":-5.609451,"marketCap":59868208},{"date":"2023-01-20","current":-6.003939,"twenty":-8.49845,"median":-6.847468,"eighty":-5.67647,"marketCap":61390281},{"date":"2023-01-27","current":-6.103178,"twenty":-8.420868,"median":-6.835891,"eighty":-5.709979,"marketCap":62404997},{"date":"2023-02-03","current":-7.294042,"twenty":-8.382328,"median":-6.835891,"eighty":-5.740388,"marketCap":74581581},{"date":"2023-02-10","current":-5.855081,"twenty":-8.337106,"median":-6.74823,"eighty":-5.755843,"marketCap":59868208},{"date":"2023-02-17","current":-5.681414,"twenty":-8.276789,"median":-6.583594,"eighty":-5.740388,"marketCap":58092456},{"date":"2023-02-24","current":-5.21003,"twenty":-8.249982,"median":-6.4676,"eighty":-5.666736,"marketCap":53272558},{"date":"2023-03-03","current":-5.557365,"twenty":-8.111944,"median":-6.366761,"eighty":-5.512003,"marketCap":56824062},{"date":"2023-03-10","current":-5.309269,"twenty":-7.978789,"median":-6.300699,"eighty":-5.458127,"marketCap":54287273},{"date":"2023-03-17","current":-5.110791,"twenty":-7.939094,"median":-6.266233,"eighty":-5.368812,"marketCap":52257843},{"date":"2023-03-24","current":-4.88552,"twenty":-7.92917,"median":-6.24238,"eighty":-5.269573,"marketCap":49954439},{"date":"2023-03-31","current":-4.961933,"twenty":-7.889474,"median":-6.199214,"eighty":-5.170335,"marketCap":50735770},{"date":"2023-04-06","current":-4.451351,"twenty":-7.889474,"median":-6.103178,"eighty":-5.110791,"marketCap":45515059},{"date":"2023-04-14","current":-3.652946,"twenty":-7.841169,"median":-6.065177,"eighty":-5.011553,"marketCap":50735770},{"date":"2023-04-21","current":-3.579887,"twenty":-7.77415,"median":-6.003939,"eighty":-4.88552,"marketCap":49721054},{"date":"2023-04-28","current":-4.237418,"twenty":-7.690997,"median":-5.94273,"eighty":-4.763456,"marketCap":58853493},{"date":"2023-05-05","current":-5.338865,"twenty":-7.640113,"median":-5.897631,"eighty":-4.763456,"marketCap":74151500},{"date":"2023-05-12","current":-5.229163,"twenty":-7.559691,"median":-5.855081,"eighty":-4.763456,"marketCap":72627839},{"date":"2023-05-19","current":-4.023678,"twenty":-7.501933,"median":-5.855081,"eighty":-4.709867,"marketCap":65517550},{"date":"2023-05-26","current":-4.024074,"twenty":-7.44975,"median":-5.755843,"eighty":-4.56736,"marketCap":65524000},{"date":"2023-06-02","current":-4.117657,"twenty":-7.38182,"median":-5.730085,"eighty":-4.532825,"marketCap":67047814},{"date":"2023-06-09","current":-4.460795,"twenty":-7.341609,"median":-5.681414,"eighty":-4.479534,"marketCap":72635132},{"date":"2023-06-16","current":-4.616767,"twenty":-7.320735,"median":-5.557365,"eighty":-4.462971,"marketCap":75174822},{"date":"2023-06-23","current":-3.961685,"twenty":-7.26427,"median":-5.518388,"eighty":-4.381711,"marketCap":64508124},{"date":"2023-06-29","current":-3.649742,"twenty":-7.204727,"median":-5.507746,"eighty":-4.30418,"marketCap":59428744},{"date":"2023-07-07","current":-3.649742,"twenty":-7.125336,"median":-5.482937,"eighty":-4.261724,"marketCap":59428744},{"date":"2023-07-14","current":-3.961685,"twenty":-7.075717,"median":-5.458127,"eighty":-4.213206,"marketCap":64508124},{"date":"2023-07-21","current":-3.774519,"twenty":-7.026098,"median":-5.383698,"eighty":-4.098941,"marketCap":61460496},{"date":"2023-07-28","current":-3.899297,"twenty":-6.996326,"median":-5.309269,"eighty":-4.055269,"marketCap":63492248},{"date":"2023-08-04","current":-4.055269,"twenty":-6.976478,"median":-5.305784,"eighty":-4.024074,"marketCap":66031938},{"date":"2023-08-11","current":-3.71213,"twenty":-6.946707,"median":-5.229163,"eighty":-4.023836,"marketCap":60444620},{"date":"2023-08-18","current":-2.988542,"twenty":-6.926859,"median":-5.21003,"eighty":-3.967924,"marketCap":55900678},{"date":"2023-08-25","current":-2.62068,"twenty":-6.886013,"median":-5.11946,"eighty":-3.951783,"marketCap":49019813},{"date":"2023-09-01","current":-2.513364,"twenty":-6.860627,"median":-5.110791,"eighty":-3.930259,"marketCap":47012470},{"date":"2023-09-08","current":-2.526676,"twenty":-6.847468,"median":-5.078563,"eighty":-3.899297,"marketCap":47261483},{"date":"2023-09-15","current":-2.608182,"twenty":-6.845153,"median":-5.011553,"eighty":-3.899297,"marketCap":48786047},{"date":"2023-09-22","current":-2.55303,"twenty":-6.835891,"median":-4.985845,"eighty":-3.868102,"marketCap":47754425},{"date":"2023-09-29","current":-2.744025,"twenty":-6.835891,"median":-4.94159,"eighty":-3.811953,"marketCap":51326986},{"date":"2023-10-06","current":-2.716856,"twenty":-6.822487,"median":-4.891519,"eighty":-3.800394,"marketCap":50818799},{"date":"2023-10-13","current":-2.771193,"twenty":-6.764744,"median":-4.855748,"eighty":-3.674864,"marketCap":51835174},{"date":"2023-10-20","current":-2.798362,"twenty":-6.718458,"median":-4.788265,"eighty":-3.649454,"marketCap":52343362},{"date":"2023-10-27","current":-3.070048,"twenty":-6.658915,"median":-4.763456,"eighty":-3.617001,"marketCap":57425242},{"date":"2023-11-03","current":-2.825531,"twenty":-6.599372,"median":-4.741545,"eighty":-3.370093,"marketCap":52851550},{"date":"2023-11-10","current":-2.698925,"twenty":-6.580438,"median":-4.615683,"eighty":-3.134857,"marketCap":50483394},{"date":"2023-11-17","current":-1.794049,"twenty":-6.547711,"median":-4.614598,"eighty":-2.977674,"marketCap":48277859},{"date":"2023-11-24","current":-1.801141,"twenty":-6.480942,"median":-4.562994,"eighty":-2.907036,"marketCap":48468704},{"date":"2023-12-01","current":-1.801331,"twenty":-6.400894,"median":-4.539119,"eighty":-2.825531,"marketCap":48473807},{"date":"2023-12-08","current":-1.818396,"twenty":-6.387241,"median":-4.499481,"eighty":-2.798362,"marketCap":48933032},{"date":"2023-12-15","current":-1.668601,"twenty":-6.340719,"median":-4.456073,"eighty":-2.771193,"marketCap":44902052},{"date":"2023-12-22","current":-1.763408,"twenty":-6.301655,"median":-4.366782,"eighty":-2.771193,"marketCap":47453305},{"date":"2023-12-29","current":-2.028867,"twenty":-6.301655,"median":-4.301004,"eighty":-2.716856,"marketCap":54596814},{"date":"2024-01-05","current":-2.028867,"twenty":-6.300507,"median":-4.273208,"eighty":-2.716856,"marketCap":54596814},{"date":"2024-01-12","current":-1.971983,"twenty":-6.279637,"median":-4.250234,"eighty":-2.709684,"marketCap":53066062},{"date":"2024-01-19","current":-1.915288,"twenty":-6.266233,"median":-4.226786,"eighty":-2.63785,"marketCap":51540413},{"date":"2024-01-26","current":-1.953022,"twenty":-6.266233,"median":-4.21124,"eighty":-2.608182,"marketCap":52555811},{"date":"2024-02-02","current":-1.971983,"twenty":-6.260554,"median":-4.10206,"eighty":-2.583187,"marketCap":53066062},{"date":"2024-02-09","current":-1.915099,"twenty":-6.244311,"median":-4.059,"eighty":-2.580851,"marketCap":51535310},{"date":"2024-02-16","current":-1.990944,"twenty":-6.220601,"median":-4.055269,"eighty":-2.537218,"marketCap":53576313},{"date":"2024-02-23","current":-2.06679,"twenty":-6.201776,"median":-4.039471,"eighty":-2.526676,"marketCap":55617315},{"date":"2024-03-01","current":-8.0017,"twenty":-6.226663,"median":-4.024074,"eighty":-2.502279,"marketCap":215325753},{"date":"2024-03-08","current":-4.269974,"twenty":-6.201776,"median":-4.055269,"eighty":-2.516026,"marketCap":114904991},{"date":"2024-03-15","current":-3.738781,"twenty":-6.192512,"median":-4.054869,"eighty":-2.526676,"marketCap":100610590},{"date":"2024-03-22","current":-4.147391,"twenty":-6.1532,"median":-4.055269,"eighty":-2.526676,"marketCap":111606283},{"date":"2024-03-28","current":-3.964999,"twenty":-6.103178,"median":-4.055269,"eighty":-2.526676,"marketCap":101710160},{"date":"2024-04-05","current":-4.286449,"twenty":-6.065177,"median":-4.055269,"eighty":-2.526676,"marketCap":109956000},{"date":"2024-04-12","current":-4.393611,"twenty":-6.065177,"median":-4.07255,"eighty":-2.55303,"marketCap":112704900},{"date":"2024-04-19","current":-3.868521,"twenty":-6.065177,"median":-4.086099,"eighty":-2.553845,"marketCap":99235290},{"date":"2024-04-26","current":-3.632766,"twenty":-6.053559,"median":-4.055269,"eighty":-2.579112,"marketCap":93187710},{"date":"2024-05-03","current":-3.686378,"twenty":-6.003939,"median":-4.054869,"eighty":-2.580742,"marketCap":94562959},{"date":"2024-05-10","current":-3.686378,"twenty":-5.95432,"median":-4.027035,"eighty":-2.581014,"marketCap":94562959},{"date":"2024-05-17","current":-4.268615,"twenty":-5.95432,"median":-4.024808,"eighty":-2.581014,"marketCap":108307576},{"date":"2024-05-24","current":-3.5319,"twenty":-5.93114,"median":-4.024074,"eighty":-2.581014,"marketCap":89614897},{"date":"2024-05-31","current":-3.553568,"twenty":-5.909989,"median":-4.024074,"eighty":-2.581014,"marketCap":90164682},{"date":"2024-06-07","current":-3.488564,"twenty":-5.899045,"median":-4.023678,"eighty":-2.58536,"marketCap":88515328},{"date":"2024-06-14","current":-3.510232,"twenty":-5.874491,"median":-4.004377,"eighty":-2.598364,"marketCap":89065113},{"date":"2024-06-21","current":-2.708512,"twenty":-5.857471,"median":-3.98693,"eighty":-2.607058,"marketCap":68723081},{"date":"2024-06-28","current":-2.751848,"twenty":-5.855878,"median":-3.985865,"eighty":-2.607807,"marketCap":69822650},{"date":"2024-07-05","current":-2.62184,"twenty":-5.855081,"median":-3.965262,"eighty":-2.608182,"marketCap":66523942},{"date":"2024-07-12","current":-2.860189,"twenty":-5.855081,"median":-3.963325,"eighty":-2.608182,"marketCap":72571573},{"date":"2024-07-15","current":-2.903525,"twenty":-5.855081,"median":-3.961685,"eighty":-2.608182,"marketCap":73671143},{"date":"2024-08-02","current":-2.62184,"twenty":-5.855081,"median":-3.961685,"eighty":-2.608182,"marketCap":66523942},{"date":"2024-08-09","current":-2.513499,"twenty":-5.855081,"median":-3.961685,"eighty":-2.600172,"marketCap":63775019},{"date":"2024-08-16","current":-2.884876,"twenty":-5.855081,"median":-3.943309,"eighty":-2.581014,"marketCap":69822650},{"date":"2024-08-23","current":-3.082073,"twenty":-5.805462,"median":-3.930491,"eighty":-2.586447,"marketCap":74595405},{"date":"2024-08-30","current":-2.990752,"twenty":-5.755843,"median":-3.930297,"eighty":-2.600172,"marketCap":72385171},{"date":"2024-09-06","current":-2.785281,"twenty":-5.755843,"median":-3.903974,"eighty":-2.605081,"marketCap":67412144},{"date":"2024-09-13","current":-2.830941,"twenty":-5.735237,"median":-3.899297,"eighty":-2.607807,"marketCap":68517261},{"date":"2024-09-20","current":-2.808111,"twenty":-5.703277,"median":-3.899297,"eighty":-2.608182,"marketCap":67964702},{"date":"2024-09-27","current":-2.568394,"twenty":-5.684446,"median":-3.868521,"eighty":-2.608182,"marketCap":62162838},{"date":"2024-10-04","current":-2.556979,"twenty":-5.666736,"median":-3.868102,"eighty":-2.605081,"marketCap":61886558},{"date":"2024-10-11","current":-2.534149,"twenty":-5.578505,"median":-3.86779,"eighty":-2.590269,"marketCap":61334000},{"date":"2024-10-18","current":-2.876601,"twenty":-5.557365,"median":-3.847356,"eighty":-2.590269,"marketCap":69622378},{"date":"2024-10-25","current":-2.853771,"twenty":-5.534696,"median":-3.836405,"eighty":-2.598382,"marketCap":69069820},{"date":"2024-10-31","current":-3.059243,"twenty":-5.516259,"median":-3.813585,"eighty":-2.601652,"marketCap":74042847},{"date":"2024-11-08","current":-2.876601,"twenty":-5.507746,"median":-3.805714,"eighty":-2.60484,"marketCap":69622378},{"date":"2024-11-15","current":-3.391375,"twenty":-5.507746,"median":-3.799064,"eighty":-2.607432,"marketCap":79568432},{"date":"2024-11-22","current":-3.132311,"twenty":-5.477975,"median":-3.725455,"eighty":-2.608182,"marketCap":73490288},{"date":"2024-11-29","current":-3.635579,"twenty":-5.458127,"median":-3.707794,"eighty":-2.608182,"marketCap":85297952},{"date":"2024-12-06","current":-3.256873,"twenty":-5.458127,"median":-3.686378,"eighty":-2.609269,"marketCap":76412748},{"date":"2024-12-13","current":-3.28212,"twenty":-5.438279,"median":-3.666018,"eighty":-2.614811,"marketCap":77005095},{"date":"2024-12-20","current":-2.979155,"twenty":-5.408507,"median":-3.649742,"eighty":-2.621144,"marketCap":69896933},{"date":"2024-12-27","current":-3.004402,"twenty":-5.398583,"median":-3.649382,"eighty":-2.62184,"marketCap":70489279},{"date":"2025-01-03","current":-3.029649,"twenty":-5.358888,"median":-3.643482,"eighty":-2.62184,"marketCap":71081626},{"date":"2025-01-10","current":-3.080143,"twenty":-5.34287,"median":-3.635579,"eighty":-2.62184,"marketCap":72266320},{"date":"2025-01-17","current":-3.054896,"twenty":-5.315188,"median":-3.625669,"eighty":-2.624743,"marketCap":71673973},{"date":"2025-01-24","current":-3.029649,"twenty":-5.309269,"median":-3.617859,"eighty":-2.625469,"marketCap":71081626},{"date":"2025-01-31","current":-2.953908,"twenty":-5.309269,"median":-3.616417,"eighty":-2.631398,"marketCap":69304586},{"date":"2025-02-07","current":-2.928661,"twenty":-5.305086,"median":-3.579536,"eighty":-2.6391,"marketCap":68712239},{"date":"2025-02-14","current":-2.903414,"twenty":-5.276709,"median":-3.559838,"eighty":-2.645619,"marketCap":68119892},{"date":"2025-02-21","current":-2.979155,"twenty":-5.247455,"median":-3.553568,"eighty":-2.65505,"marketCap":69896933},{"date":"2025-02-28","current":-2.802425,"twenty":-5.22151,"median":-3.553568,"eighty":-2.667558,"marketCap":65750504},{"date":"2025-03-07","current":-2.751931,"twenty":-5.21003,"median":-3.5319,"eighty":-2.67113,"marketCap":64565811},{"date":"2025-03-14","current":-2.67619,"twenty":-5.21003,"median":-3.521066,"eighty":-2.656636,"marketCap":62788770},{"date":"2025-03-21","current":-2.777178,"twenty":-5.190182,"median":-3.493456,"eighty":-2.667558,"marketCap":65158157},{"date":"2025-03-28","current":-2.903414,"twenty":-5.144031,"median":-3.480309,"eighty":-2.67113,"marketCap":68119892},{"date":"2025-04-04","current":-2.496906,"twenty":-5.115992,"median":-3.458849,"eighty":-2.650943,"marketCap":58642342},{"date":"2025-04-11","current":-2.547702,"twenty":-5.110791,"median":-3.374618,"eighty":-2.63785,"marketCap":59835332},{"date":"2025-04-17","current":-2.648601,"twenty":-5.110791,"median":-3.357861,"eighty":-2.625696,"marketCap":62205048},{"date":"2025-04-25","current":-2.598152,"twenty":-5.110791,"median":-3.312934,"eighty":-2.623795,"marketCap":61020190},{"date":"2025-05-02","current":-2.623376,"twenty":-5.0979,"median":-3.294018,"eighty":-2.622147,"marketCap":61612619},{"date":"2025-05-09","current":-2.572927,"twenty":-5.039379,"median":-3.256873,"eighty":-2.620912,"marketCap":60427761},{"date":"2025-05-16","current":-2.569379,"twenty":-5.011553,"median":-3.231626,"eighty":-2.608725,"marketCap":61020190},{"date":"2025-05-23","current":-2.843779,"twenty":-5.011553,"median":-3.195963,"eighty":-2.608725,"marketCap":67536909},{"date":"2025-05-30","current":-2.993452,"twenty":-5.011553,"median":-3.178063,"eighty":-2.610899,"marketCap":71091483},{"date":"2025-06-06","current":-2.843827,"twenty":-5.009757,"median":-3.164628,"eighty":-2.62068,"marketCap":67538049},{"date":"2025-06-13","current":-2.968556,"twenty":-4.961933,"median":-3.143124,"eighty":-2.62184,"marketCap":70500244},{"date":"2025-06-16","current":-2.868773,"twenty":-4.961933,"median":-3.137717,"eighty":-2.62184,"marketCap":68130488}],"updateTime":1750172096967}}}